Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 105,000,216
- Total 13F shares
- 45,482,453
- Share change
- -207,979
- Total reported value
- $997,426,956
- Price per share
- $21.95
- Number of holders
- 114
- Value change
- -$15,117,112
- Number of buys
- 53
- Number of sells
- 52
Report period
Q1 2022
Institutions
114
Top holders
10
CRNX full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.9%
|
5,163,517
|
$146,696,000 | — | 31 Dec 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.6%
|
4,793,638
|
$136,187,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
3.5%
|
3,722,295
|
$105,751,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
3,276,170
|
$93,077,000 | — | 31 Dec 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3%
|
3,196,876
|
$90,823,000 | — | 31 Dec 2021 | |
| BVF INC/IL |
13F
|
Company |
2.9%
|
3,003,879
|
$85,340,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
2,096,898
|
$59,572,000 | — | 31 Dec 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.9%
|
2,029,701
|
$57,664,000 | — | 31 Dec 2021 | |
| Deep Track Capital, LP |
13F
|
Company |
1.8%
|
1,900,000
|
$53,979,000 | — | 31 Dec 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,384,293
|
$39,328,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
1,300,374
|
$36,944,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
1,104,476
|
$31,378,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
1,070,272
|
$30,407,000 | — | 31 Dec 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.82%
|
862,286
|
$24,498,000 | — | 31 Dec 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.79%
|
827,480
|
$23,509,000 | — | 31 Dec 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.69%
|
724,400
|
$20,580,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
698,738
|
$19,851,000 | — | 31 Dec 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.56%
|
590,169
|
$16,767,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
450,528
|
$12,800,000 | — | 31 Dec 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.4%
|
423,248
|
$12,024,000 | — | 31 Dec 2021 | |
| Versant Venture Management, LLC |
13F
|
Company |
0.39%
|
410,360
|
$11,658,000 | — | 31 Dec 2021 | |
| MPM BioImpact LLC |
13F
|
Company |
0.36%
|
379,792
|
$10,790,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
345,444
|
$9,814,000 | — | 31 Dec 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.32%
|
331,000
|
$9,404,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
322,506
|
$9,163,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.28%
|
295,512
|
$7,160,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
289,735
|
$8,232,000 | — | 31 Dec 2021 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.26%
|
272,796
|
$7,750,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
190,235
|
$5,404,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
152,400
|
$4,330,000 | — | 31 Dec 2021 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.13%
|
141,000
|
$4,006,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.13%
|
137,292
|
$3,900,000 | — | 31 Dec 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.11%
|
118,344
|
$3,362,000 | — | 31 Dec 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.11%
|
114,768
|
$3,261,000 | — | 31 Dec 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
111,860
|
$3,178,000 | — | 31 Dec 2021 | |
| Global IMC LLC |
13F
|
Company |
0.09%
|
97,147
|
$2,760,000 | — | 31 Dec 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.08%
|
87,608
|
$2,489,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.07%
|
76,822
|
$2,183,000 | — | 31 Dec 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
71,000
|
$2,017,000 | — | 31 Dec 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.06%
|
68,200
|
$1,938,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
68,096
|
$1,935,000 | — | 31 Dec 2021 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.06%
|
66,948
|
$1,902,000 | — | 31 Dec 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.06%
|
66,782
|
$1,897,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
64,824
|
$1,842,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
61,520
|
$1,748,000 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
57,787
|
$1,642,000 | — | 31 Dec 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.05%
|
54,964
|
$1,562,000 | — | 31 Dec 2021 | |
| HighVista Strategies LLC |
13F
|
Company |
0.05%
|
52,982
|
$1,505,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
52,820
|
$1,500,000 | — | 31 Dec 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
52,392
|
$1,488,000 | — | 31 Dec 2021 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) as of Q1 2022
As of 31 Mar 2022,
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,482,453 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, FMR LLC, BlackRock Inc., ORBIMED ADVISORS LLC, BVF INC/IL, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, and Deep Track Capital, LP.
This page lists
114
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
114
Q1 2022 holders
114
Holder diff
0
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.